Juvenile dermatomyositis. Where are we now?
McCann LJ, Livermore P, Wilkinson MGL, Wedderburn LR.
Clin Exp Rheumatol. 2022 Feb;40(2):394-403. doi: 10.55563/clinexprheumatol/56ilob. Epub 2022 Feb 7.
Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI).
Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, Herbelin L, Barohn R, Isenberg D, Miller FW.
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11(0 11):S118-57. doi: 10.1002/acr.20532.
Juvenile Dermatomyositis: Advances in Pathogenesis, Assessment, and Management.
Leung AKC, Lam JM, Alobaida S, Leong KF, Wong AHC.
Curr Pediatr Rev. 2021;17(4):273-287. doi: 10.2174/1573396317666210426105045.
Dermatomyositis of childhood.
Lell ME, Swerdlow ML.
Pediatr Ann. 1977 Mar;6(3):203-12.
Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment.
Wu JQ, Lu MP, Reed AM.
World J Pediatr. 2020 Feb;16(1):31-43. doi: 10.1007/s12519-019-00313-8. Epub 2019 Sep 26.
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.
Feldman BM, Rider LG, Reed AM, Pachman LM.
Lancet. 2008 Jun 28;371(9631):2201-12. doi: 10.1016/S0140-6736(08)60955-1.
Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes.
Ramanan AV, Feldman BM.
Rheum Dis Clin North Am. 2002 Nov;28(4):833-57. doi: 10.1016/s0889-857x(02)00024-8.
Treatment of Juvenile Dermatomyositis: An Update.
Papadopoulou C, Wedderburn LR.
Paediatr Drugs. 2017 Oct;19(5):423-434. doi: 10.1007/s40272-017-0240-6.
Immunopathogenesis of juvenile dermatomyositis.
Khanna S, Reed AM.
Muscle Nerve. 2010 May;41(5):581-92. doi: 10.1002/mus.21669.
Dermatomyositis of childhood.
BANKER BQ.
Trans Am Neurol Assoc. 1962;87:11-5.
